What Is Metastasis?

Metastasis is the biological process by which cancer cells detach from a primary tumor, travel through the body via the bloodstream or lymphatic system, and establish secondary tumors at distant sites. It is the principal cause of cancer-related mortality, responsible for more than 90 percent of cancer deaths. The process is not a single event but a cascade of distinct steps, each representing a biological barrier that the tumor cell must overcome. Understanding this cascade is foundational to oncology and increasingly to biomedical engineering, where devices and computational models are developed to detect, monitor, and interrupt metastatic progression.

The biology of metastasis draws from cell biology, molecular biology, and pathology. The capacity to metastasize is considered one of the defining hallmarks of malignancy and distinguishes invasive cancer from benign neoplasms. As reviewed in Nature's Signal Transduction and Targeted Therapy on mechanisms of cancer metastasis, metastatic competence involves genetic and epigenetic changes within the tumor cell as well as signals from the surrounding tumor microenvironment.

Invasion and Intravasation

The first stage of metastasis is local invasion, in which tumor cells degrade the extracellular matrix and basement membrane surrounding the primary tumor. A key driver of this process is the epithelial-mesenchymal transition (EMT), a reprogramming event in which epithelial cells lose their characteristic adhesion molecule E-cadherin and gain mesenchymal markers such as vimentin. This shift endows cells with increased motility and resistance to anoikis (programmed death triggered by loss of cell adhesion). Once a tumor cell penetrates the surrounding tissue, it intravasates by crossing the wall of a nearby blood vessel or lymphatic capillary, entering circulation as a circulating tumor cell (CTC). Intravasation requires active remodeling of the vascular wall, facilitated by matrix metalloproteinases and signals from tumor-associated macrophages.

Circulation and Extravasation

Circulating tumor cells face severe attrition in the bloodstream: mechanical shear stress, immune surveillance by natural killer cells, and the lack of survival signals that solid tissue normally provides. Only a small fraction survive transit. Those that do often arrest in small-diameter capillary beds in distant organs. Extravasation, the exit from the vasculature into the new tissue, recapitulates the invasion step in reverse: the cell adheres to the endothelial wall, penetrates the vessel, and enters the organ parenchyma. The NIH-archived review of metastasis mechanisms documents how organ-specific adhesion molecules and chemokine gradients guide CTCs toward preferred secondary sites, explaining why certain cancers show predictable metastatic patterns (breast cancer to bone, colon cancer to liver).

Colonization and Secondary Tumors

Arrival at a distant site does not guarantee successful metastasis. Many disseminated cells enter a dormant state, surviving for years without proliferating, held in check by immune pressure or an unsupportive local environment. Outgrowth into a clinically detectable secondary tumor requires a compatible tumor microenvironment: local stromal cells, vasculature, and growth factor availability must collectively support proliferation. This stage, termed colonization, is now recognized as a major therapeutic target. Research described in the American Association for Cancer Research's hallmarks of metastasis framework identifies traits such as metabolic plasticity and immune evasion as requirements for successful colonization, distinct from the traits needed at earlier steps.

Applications

Metastasis research has applications in a range of fields, including:

• Oncology diagnostics, including liquid biopsy platforms that detect circulating tumor cells and cell-free DNA in blood
• Biomedical engineering of microfluidic devices that model the tumor microenvironment and vascular extravasation in vitro
• Drug development, targeting EMT pathways, matrix metalloproteinases, and dormancy-to-proliferation transitions
• Radiation therapy planning, where understanding metastatic spread patterns guides treatment of secondary sites
• Computational modeling and simulation of cancer progression and organ-specific tropism